GSK press release (GSK): Q3 Non-GAAP EPS of £0.55 beats by £0.04. – Revenue of £8.89B (+4.0% Y/Y) beats by £50M. – Specialty Medicines sales £3.9 billion (+15%); HIV sales £2.1 billion (+10%), Respiratory, Immunology & Inflammation £1.1 billion (+21%); Oncology £0.6…
GSK Non-gaap EPS of £0.55 Beats by £0.04, Revenue of £8.89b Beats by £50M; Reaffirms FY Outlook
GSK press release (GSK): Q3 Non-GAAP EPS of £0.55 beats by £0.04. - Revenue of £8.89B (+4.0% Y/Y) beats by £50M. - Specialty Medicines sales £3.9 billion (+15%); HIV sales £2.1 billion (+10%), Respiratory, Immunology & Inflammation £1.1 billion (+21%); Oncology £0.6...</p